TD Cowen Downgrades ADC Therapeutics to Market Perform

Benzinga ·  11/09/2023 20:29

TD Cowen analyst Boris Peaker downgrades ADC Therapeutics (NYSE:ADCT) from Outperform to Market Perform.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment